COVID-19 Resources for You and Your Patients

Want to reserve your NUVAXOVID vaccines for the 2025-2026 season?

By clicking this button, you will be redirected to VaccineShop.com

Order Now

Resources for your patients

Your patients can find where to get a NUVAXOVID vaccine in their area by using the vaccine locator

Resources for your practice

One-Page Fact Sheet

Quick guide to NUVAXOVID for healthcare professionals.

See Fact Sheet

Pharmacist/Patient Pocket Guide

Information about NUVAXOVID for pharmacists and patients.

See Pocket Guide

Coding and Reimbursement Guide

Details on coding and reimbursement for NUVAXOVID.

See Guide for Details

To request printed materials, contact your Sanofi vaccines representative or call 1-800-VACCINE.

You can easily order NUVAXOVID for your practice today!

Order NUVAXOVID

Your patients can find a NUVAXOVID vaccine near them by using the COVID-19 vaccine locator.

Vaccine Locator

ACIP=Advisory Committee on Immunization Practices.

INDICATION

NUVAXOVID is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). NUVAXOVID is approved for use in individuals who are:

65 years of age and older, or
12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATION
Do not administer NUVAXOVID to individuals with a known history of severe allergic reaction (e.g., anaphylaxis) to any component of NUVAXOVID or to individuals who had a severe allergic reaction (e.g.,anaphylaxis) following a previous dose of NUVAXOVID

MANAGEMENT OF ACUTE ALLERGIC REACTIONS
Appropriate medical treatment must be immediately available to manage potential anaphylactic reactions following administration of NUVAXOVID

MYOCARDITIS AND PERICARDITIS
Clinical trials data provide evidence for increased risks of myocarditis and pericarditis following administration of NUVAXOVID. There have been post-marketing reports of myocarditis and pericarditis following administration of NUVAXOVID

SYNCOPE
Syncope (fainting) may occur in association with administration of injectable vaccines, including NUVAXOVID. Procedures should be in place to avoid injury from fainting

ALTERED IMMUNOCOMPETENCE
Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished immune response to NUVAXOVID

COMMON ADVERSE REACTIONS
The most commonly reported (> 10%) solicited adverse reactions included: injection site pain/tenderness, fatigue/malaise, muscle pain, headache, nausea/vomiting, fever, and joint pain

Learn more about Sanofi’s commitment to fighting counterfeit drugs